Dr. Neil Kay, MD

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Suny Upstate Medical University Hospital

  Fellowship Hospital

• Winnipeg General Hospital

  Internship Hospital

• The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis, 2022-11-22

• Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis, 2013-09-20

• Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia, 2019-01-01

• Relationship among three common hematological premalignant conditions, 2023-05-05

• GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity, 2022-04-19

• Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E2903), 2019-07-23

• Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison tode novoHodgkin lymphoma, 2015-01-30

• The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells, 2013-12-23

• CD5-positive chronic B-cell lymphoproliferative disorders: Diagnosis and prognosis of a heterogeneous disease entity, 2010-07-27

• A Phase I Clinical Trial of CpG Oligonucleotide 7909 (PF-03512676) in Patients with Previously Treated Chronic Lymphocytic Leukemia, 2011-09-19

• Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib, 2022-09-01

• Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index, 2021-08-05

• Tris (dibenzylideneacetone) Dipalladium: A Small-Molecule Palladium Complex Is Effective in Inducing Apoptosis in Chronic Lymphocytic Leukemia B-Cells, 2016-05-17

• Risk Model for Overall Survival in Relapsed or Refractory Chronic Lymphocytic Leukaemia in the Era of Targeted Therapies, 2019-05-17

• Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis, 2013-07-01

• Bone Marrow Stromal Cells Protect Lymphoma B-cells from Rituximab-Induced Apoptosis and Targeting Integrin alfa-4-beta-1 (VLA-4) with Natalizumab can Overcome this Resistance, 2011-07-12

• Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis, 2022-02-15

• Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL), 2020-03-18

• Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy, 2018-12-14

• Biological Evaluation of CpG Stimulation of Normal Human B-Cells: Implications for B-Cell Biology and Cytogenetic Analysis of CLL B-Cells, 2011-02-17

• Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia, 2016-03-09

• KRAS,NRAS, andBRAFmutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival, 2019-03-14

• Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans, 2021-07-20

• B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells, 2022-07-01

• Vaccination History and Risk of Lymphoma and Its Major Subtypes, 2021-11-15

• Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-Cell Expansion, Trafficking, and Toxicity, 2021-07-08

• Bi-directional Activation between Mesenchymal Stem Cells and CLL B-Cells: Implication for CLL Disease Progression, 2009-09-08

• Upregulation of AXL and ß-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance, 2021-02-18

• Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group, 2009-02-24

• Chronic lymphocytic leukemia in 2020: a surfeit of riches?, 2020-05-11

• Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium, 2013-07-16

• Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis, 2007-05-08

• Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated CLL, 2013-08-06

• A Two-Stage Evaluation of Genetic Variation in Immune and Inflammation Genes with Risk of Non-Hodgkin Lymphoma Identifies New Susceptibility Locus in 6p21.3 Region, 2012-08-21

• Computational Identification Of CDR3 Sequence Archetypes Among Immunoglobulin Sequences in Chronic Lymphocytic Leukemia, 2008-07-21

• Akt inhibitor MK-2206 in combination with Bendamustine and Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results from the N1087 Alliance Study, 2017-06-01

• A Comprehensive Evaluation of the Prognostic Significance of 13q Deletions in Patients with B-Chronic Lymphocytic Leukemia, 2009-11-06

• Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?, 2022-01-28

• Identification of recurrent truncatedDDX3Xmutations in chronic lymphocytic leukaemia, 2014-11-10

• Axl Activates Fibroblast Growth Factor Receptor Pathway to Potentiate Survival Signals in B-Cell Chronic Lymphocytic Leukemia Cells, 2015-11-24

• Axl Inhibition Primes Chronic Lymphocytic Leukemia B-Cells to Apoptosis and Show Synergistic/Additive Effects in Combination with BTK inhibitors, 2015-02-11

• Progressive but Previously Untreated CLL Patients with Greater Array CGH Complexity Exhibit a Less Durable Response to Chemoimmunotherapy, 2010-09-14

• Experimental Designs for Array Comparative Genomic Hybridization (aCGH) Technology, 2013-03-27

• Acquired Chromosomal Anomalies in Chronic Lymphocytic Leukemia (CLL) Patients Compared to >50,000 Quasi-normal Subjects, 2014-01-17

• The Tumor Suppressor Axis p53/miR-34a Regulates Axl Expression in B-Cell Chronic Lymphocytic Leukemia: Implications for Therapy in p53-Defective CLL Patients, 2013-10-18

• Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice, 2019-04-24

• Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia, 2022-07-12

• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre, 2018-08-16

• Incidence of Chronic Lymphocytic Leukemia and High Count Monoclonal B-cell Lymphocytosis using the 2008 Guidelines, 2014-04-07

• Autoimmune Cytopenia in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL): Changes in Clinical Presentation and Prognosis, 2014-01-31

• Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia, 2021-03-02

• Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis, 2019-08-05

• A NOVEL METHOD FOR ANALYSIS OF HUMAN T CELL REPERTOIRES BY REAL-TIME PCR, 2014-06-28

• Genetic Variation inTNFand the NF-?B Canonical Pathway and Risk of Non-Hodgkin Lymphoma, 2009-05-12

• Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia, 2021-04-15

• Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia, 2021-01-15

• Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence, 2008-04-18

• Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab, 2008-10-15

• Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL), 2012-07-03

• Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings, 2017-10-19

• Large-scale analysis of DNA methylation in chronic lymphocytic leukemia, 2010-05-05

• The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice, 2020-03-18

• IGHtranslocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes, 2019-01-08

• SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis, 2021-05-17

• Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome, 2023-01-09

• The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL), 2021-01-16

• The Dohner fluorescencein situhybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience, 2016-02-05

• Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes, 2020-06-01

• Bone Marrow Hematopoietic Dysfunction in Untreated Chronic Lymphocytic Leukemia Patients, 2018-10-05

• Hematologist/Oncologist Disease-Specific Expertise and Survival: Lessons from Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL), 2011-08-26

• Dynamics of Microvesicle Generation in B Cell Chronic Lymphocytic Leukemia: Implication in Disease Progression, 2016-08-02

• Pharmacovigilance during Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) in Routine Clinical Practice, 2016-11-08

• Addition of GM-CSF Does Not Improve Response to Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab and Rituximab, 2012-08-22

• Hypogammaglobulinemia in Newly Diagnosed Chronic Lymphocytic Leukemia: Natural History, Clinical Correlates and Outcomes, 2015-04-30

• Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index, 2020-05-07

• Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study, 2016-04-24

• Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis, 2021-11-05

• Pentostatin and Rituximab Therapy for Previously Untreated B-CLL, 2010-05-01

• Validation of a New Prognostic Index for Patients With Chronic Lymphocytic Leukemia (CLL), 2009-01-15

• Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect®CLL Registry, 2020-07-26

• Familial CLL: What Does It Mean to Me?, 2011-03-07

• Stimulation of Chronic Lymphocytic Leukemia (CLL) Cells with CpG Oligodeoxynucleotide (ODN) Gives Consistent Karyotypic Results among Laboratories: a CLL Research Consortium (CRC)hStudy, 2010-07-30

• Diffuse Large B-Cell Lymphoma (Richter Syndrome) in Patients with Chronic Lymphocytic Leukaemia: A Cohort Study of Newly Diagnosed Patients, 2013-07-11

• Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma, 2021-03-08

• Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome, 2021-05-10

• The chronic lymphocytic leukemia international prognostic index (CLL-IPI) predicts time to first treatment in early CLL: Independent Validation in a Prospective Cohort of Early Stage Patients, 2016-08-08

• Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, 2018-08-18

• Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia, 2020-07-16